Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer

AG Tavianatou, I Caon, M Franchi… - The FEBS …, 2019 - Wiley Online Library
Hyaluronan (HA) is a linear nonsulfated glycosaminoglycan of the extracellular matrix that
plays a pivotal role in a variety of biological processes. High‐molecular weight HA exhibits …

Hyaluronic acid for anticancer drug and nucleic acid delivery

F Dosio, S Arpicco, B Stella, E Fattal - Advanced drug delivery reviews, 2016 - Elsevier
Hyaluronic acid (HA) is widely used in anticancer drug delivery, since it is biocompatible,
biodegradable, non-toxic, and non-immunogenic; moreover, HA receptors are …

Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy

R Silva, V Vilas-Boas, H Carmo… - Pharmacology & …, 2015 - Elsevier
Abstract P-glycoprotein (P-gp) is an ATP-dependent efflux pump encoded by the MDR1
gene in humans, known to mediate multidrug resistance of neoplastic cells to cancer …

Hyaluronic acid as a modern approach in anticancer therapy-review

M Michalczyk, E Humeniuk, G Adamczuk… - International Journal of …, 2022 - mdpi.com
Hyaluronic acid (HA) is a linear polysaccharide and crucial component of the extracellular
matrix (ECM), maintaining tissue hydration and tension. Moreover, HA contributes to …

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian …

LYW Bourguignon, K Peyrollier, W Xia… - Journal of Biological …, 2008 - ASBMB
Hyaluronan (HA) is a major glycosaminoglycan in the extracellular matrix whose expression
is tightly linked to multidrug resistance and tumor progression. In this study we investigated …

Hyaluronan-CD44 interaction with protein kinase Cϵ promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to …

LYW Bourguignon, CC Spevak, G Wong, W Xia… - Journal of Biological …, 2009 - ASBMB
Multidrug resistance and disease relapse is a challenging clinical problem in the treatment
of breast cancer. In this study, we investigated the hyaluronan (HA)-induced interaction …

CD147 is a promising target of tumor progression and a prognostic biomarker

A Landras, C Reger de Moura, F Jouenne, C Lebbe… - Cancers, 2019 - mdpi.com
Microenvironment plays a crucial role in tumor development and progression. Cancer cells
modulate the tumor microenvironment, which also contribute to resistance to therapy …

New insight into p-glycoprotein as a drug target

A Breier, L Gibalova, M Seres… - Anti-Cancer Agents in …, 2013 - ingentaconnect.com
Multidrug resistance (MDR) of cancer tissue is a phenomenon in which cancer cells exhibit
reduced sensitivity to a large group of unrelated drugs with different mechanisms of …

Targeting hyaluronic acid family for cancer chemoprevention and therapy

VB Lokeshwar, S Mirza, A Jordan - Advances in cancer research, 2014 - Elsevier
Hyaluronic acid or hyaluronan (HA) is perhaps one of the most uncomplicated large
polymers that regulates several normal physiological processes and, at the same time …

Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells

BP Toole, MG Slomiany - Seminars in cancer biology, 2008 - Elsevier
Hyaluronan not only is an important structural component of extracellular matrices but also
interacts instructively with cells during embryonic development, healing processes …